 Syros Pharmaceuticals Inc NASDAQ: SYRS has agreed to acquire TYME Technologies Inc NASDAQ: TYME, including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately 60 million. Syros expects to issue. 